Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2025 , Vol 63 , Num 2
Abstract PDF Similar Articles Mail to Author
Cisplatin treatment in EMT6 murine breast cancer cells: Impact on cell viability and molecular pathways
Tuba OĞUZ 1-2 Arda KEBAPCI 1-2 Neşe AYŞİT 1-2-3
1 Istanbul Medipol University, Regenerative and Restorative Medicine Research Center (REMER), Research Institute for Health Sciences and Technologies (SABITA), Istanbul, Türkiye
2 Istanbul Medipol University, Graduate School of Health Sciences, Department of Neuroscience, Istanbul, Türkiye
3 Istanbul Medipol University, School of Medicine, Department of Medical Biology and Genetics, Istanbul, Türkiye
DOI : 10.23893/1307-2080.APS6323 Viewed : 659 - Downloaded : 93 Keywords :

Istanbul Medipol University